Annual Meeting News
See the latest annual meeting press releases. Read about schedules, agendas, outcomes, and significant decisions. Browse annual meeting announcements for insights from leading companies.
Mar 18, 2026 at 7:11 PM
TomaGold Announces Results of its Annual Meeting
MONTRÉAL--(BUSINESS WIRE)--TOMAGOLD CORPORATION (TSXV: LOT; OTCPK: TOGOF) (“TomaGold” or the “Company”) is pleased to announce the voting results of its Annual General and Special Meeting of Shareholders (the "Meeting") held earlier today. Voting at the Meeting represented a total of 93,586,414 common shares of the Company, representing 31.60% of the 296,159,260 common shares, issued and outstanding. David Grondin, Michel E. Labrousse, Jean-Sébastien Jacquetin and Caitlin Jeffs were elected to...
Mar 18, 2026 at 4:30 PM
Intercontinental Exchange Sets Date for 2026 Virtual Annual Meeting of Stockholders
ATLANTA & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), one of the world’s leading providers of financial market technology and data powering global capital markets, will hold its 2026 Annual Meeting of Stockholders virtually on Friday, May 15, 2026 at 8:30 a.m. Eastern Time. Stockholders of record as of the close of business on Thursday, March 19, 2026 are entitled to participate in, vote and submit questions at the Annual Meeting. Stockholders will also be able to su...
Mar 18, 2026 at 4:30 PM
Claros Mortgage Trust, Inc. Announces 2026 Annual Meeting of Stockholders
NEW YORK--(BUSINESS WIRE)--Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today announced that it will hold its 2026 Annual Meeting of Stockholders virtually on June 3, 2026, beginning at 1:00 p.m. ET. Stockholders can attend the virtual annual meeting via the internet at www.virtualshareholdermeeting.com/CMTG2026. Stockholders of record as of the close of business on April 7, 2026 will be eligible to vote their shares and submit questions electronically in advance of and du...
Mar 18, 2026 at 2:23 PM
TotalEnergies: Convening of the Annual Shareholders’ Meeting on May 29, 2026
PARIS--(BUSINESS WIRE)--The Board of Directors of TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) met on March 18, 2026 under the chairmanship of Mr. Patrick Pouyanné, Chairman and Chief Executive Officer. It has decided to convene the Ordinary and Extraordinary Shareholders’ Meeting of the Corporation on Friday, May 29, 2026. The Notice of Meeting will be published soon in France's BALO (Bulletin des Annonces Légales et Obligatoires) and will be available on the Company's website. The Board...
Mar 18, 2026 at 8:29 AM
Newron Announces Nominations to Its Board of Directors at Upcoming Annual General Meeting
MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron announces nominations to its Board of Directors at its upcoming Annual General Meeting...
Mar 18, 2026 at 7:00 AM
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 25, 2026 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s CEO, Brent Ashton, with a Question and Answ...
Mar 17, 2026 at 4:44 PM
Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced it will present new long-term AVMAPKI™ FAKZYNJA™ combination therapy (avutometinib capsules; defactinib tablets) data from the Phase 2 RAMP 201 clinical trial at the Society of Gynecologic Oncology (SGO) 2026 Annual Meeting on Women’s Cancers. Additional abstracts accepted for presentation will also be shar...
Mar 17, 2026 at 4:30 PM
Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026
BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026...
Mar 17, 2026 at 4:30 PM
Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026
SAN DIEGO--(BUSINESS WIRE)--Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026...
Mar 17, 2026 at 12:45 PM
Mauna Kea Technologies Updates Its Financial Calendar
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the update of its financial calendar for the 2026 fiscal year. Events Date Q1 2026 Sales April 15, 2026 2025 Annual Results April 22, 2026 2026 Annual General Meeting June 4, 2026 Q2 2026 Sales July 21, 2026 2026 Half-Year Results October 8, 2026 Q3 2026 Sales Octob...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.